BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7046395)

  • 1. [A study on antihypertensive and antisclerotic effects of captopril on the retinal arteriole in SHRSP (author's transl)].
    Yoshimoto H; Yamagami K; Narita K; Matsuyama S
    Nippon Ganka Gakkai Zasshi; 1982; 86(2):227-38. PubMed ID: 7046395
    [No Abstract]   [Full Text] [Related]  

  • 2. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of blood pressure responses to captopril, an orally active converting enzyme inhibitor, in rats with various forms of experimental hypertension (author's transl)].
    Mikami H; Ogihara T; Kanda T; Higaki J; Naka T; Maruyama A; Hata T; Iwanaga K; Kumahara Y
    Nihon Naibunpi Gakkai Zasshi; 1980 Feb; 56(2):180-96. PubMed ID: 6245943
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive action of captopril in angiotensin-salt hypertension.
    Muirhead EE; Brooks B; Brosius WL
    Arch Pathol Lab Med; 1980 Dec; 104(12):631-4. PubMed ID: 7002102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes to middle cerebral artery occlusion in hypertensive and normotensive rats.
    Coyle P
    Hypertension; 1984; 6(2 Pt 2):I69-74. PubMed ID: 6373599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of captopril on blood pressure in neurogenic hypertensive dogs.
    Montastruc P; Montastruc JL
    Arch Farmacol Toxicol; 1983 Apr; 9(1):47-52. PubMed ID: 6354107
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition of angioten converting enzyme by phosphryl derivatives in rats (author's transl)].
    Mikami H; Ogihara T; Morikawa T; Sakakibara S; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1443-8. PubMed ID: 6278180
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on the hypotensive effect of captopril in hypertensive patients-its mechanism (author's transl)].
    Maruyama A; Ogihara T; Naka T; Mikami H; Hata T; Nakamaru M; Higaki J; Kanda T; Kumahara Y; Iwanaga K
    Nihon Naika Gakkai Zasshi; 1980 May; 69(5):541-7. PubMed ID: 6997414
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of angiotensin I converting enzyme inhibitor, captopril, on plasma norepinephrine concentration in hypertensive patients (author's transl)].
    Hirata Y; Takeda T; Murao S; Ishii T; Nishiyama K
    Kokyu To Junkan; 1981 Jul; 29(7):699-702. PubMed ID: 7027386
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of captopril in essential hypertension (author's transl)].
    Mimran A; Targhetta R; Laroche B
    Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The long term effects of the oral converting enzyme inhibitor, captopril in hypertensive patients--the endocrinological study of its hypotensive mechanism (author's transl)].
    Ogihara T; Maruyama A; Naka T; Hata T; Mikami H; Nakamaru M; Gotoh S; Masuo K; Otsuka A; Tsuchiya T; Tabuchi Y; Ohde H; Kumahara Y; Iwanaga K; Yanaihara C; Ohkaru H; Yanaihara N
    Nihon Naibunpi Gakkai Zasshi; 1980 Oct; 56(10):1484-96. PubMed ID: 6256218
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies (author's transl)].
    Ogihara T; Maruyama A; Mikami H; Naka T; Higaki J; Kanda T; Gotoh M; Hata T; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1185-92. PubMed ID: 396402
    [No Abstract]   [Full Text] [Related]  

  • 15. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive effect of captopril in patients with mild or moderate systemic arterial hypertension].
    Savioli RM; Lima EV; Estrella LA; Puppi EJ; Praxedes JN; Nassif M; Stoeber GH; Del Nero JĂșnior E
    Arq Bras Cardiol; 1984 Jan; 42(1):67-71. PubMed ID: 6378150
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of captopril on the development of tolerance to guanethidine.
    Rankin GO; Haas GJ
    Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of captopril in severe hypertension (author's transl)].
    Elkik F; Monteiro A; Corvol P; Milliez P
    Nouv Presse Med; 1981 Apr; 10(19):1557-63. PubMed ID: 7025845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive effect of captopril on the development of genetic hypertension in SHR rats (author's transl)].
    Giudicelli JF; Freslon JL; Richer C
    Nouv Presse Med; 1981 Apr; 10(19):1547-9. PubMed ID: 6269556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.